Coeptis Therapeutics to acquire cell therapies from Deverra Therapeutics
The company's shares rose 10% after it announced plans to acquire a cell therapy in phase one clinical trials.
Source: newsoninvest.com
Stay updated with breaking news from Colleen Deaney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company's shares rose 10% after it announced plans to acquire a cell therapy in phase one clinical trials.